Our Services
Medical Information
Helpful Resources
Published on: 5/21/2026
Reversibility testing in spirometry is a lung function test that measures your breathing before and after a bronchodilator to determine if airway obstruction is reversible. It helps doctors distinguish asthma from COPD, guide treatment decisions, and evaluate key values like FEV₁ and FVC.
Below, you'll find important details on how to prepare for the test, interpretation thresholds, limitations, and follow-up steps that could impact your diagnosis.
If you're experiencing breathing issues, shortness of breath, or a persistent cough, understanding your symptoms early can make a real difference in treatment outcomes. Take a free, instant, online symptom check to better understand what may be causing your symptoms and get clear guidance on your next steps—no signup required.
Reviewed for medical accuracy: 07/10/2026
Spirometry is a simple, non-invasive test that measures how much air you can breathe in and out, and how quickly you can blow air from your lungs. One key element of spirometry is reversibility testing. Understanding reversibility testing spirometry meaning can help you and your doctor determine whether airway obstruction improves with medication—and guide a more accurate diagnosis and treatment plan.
Reversibility testing evaluates how much your lung function improves after inhaling a bronchodilator (a medicine that relaxes airway muscles). By comparing airflow measurements before and after the medication, doctors can tell if your breathing limitation is reversible (as in asthma) or largely fixed (as in chronic obstructive pulmonary disease, COPD).
Key points:
Reversibility testing helps to:
Your doctor may suggest reversibility testing if you have:
Proper preparation ensures accurate results. Your doctor or technician will ask you to:
Baseline Spirometry
– You perform a series of deep inhales and forceful exhales into the spirometer.
– Key numbers recorded: FEV₁ and FVC.
Bronchodilator Administration
– You inhale a prescribed dose of a short-acting bronchodilator (e.g., albuterol).
– Wait time is usually 10–15 minutes to allow the medication to work.
Repeat Spirometry
– You perform the same breathing maneuvers as in the baseline test.
– The spirometer records post-bronchodilator FEV₁ and FVC.
Data Comparison
– The technician or doctor compares pre- and post-bronchodilator values.
– A significant improvement indicates reversibility.
A standard benchmark for significant reversibility is:
What these results suggest:
Asthma
• Often shows marked reversibility.
• Patients may have normal lung function between attacks.
COPD
• Generally shows little or no reversibility.
• Airflow limitation tends to be progressive and less responsive to bronchodilators.
Mixed Patterns
• Some patients exhibit partial reversibility.
• May require a treatment plan that addresses both asthma-like and COPD-like features.
Reversibility testing is very safe, but consider the following:
If you're experiencing ongoing breathing issues or are unsure about your symptoms before scheduling formal testing, you can check your symptoms with a free AI-powered assessment to help identify potential causes and determine if you need immediate medical attention.
Always consult a healthcare professional if you experience:
Reversibility testing in spirometry is a useful tool, but it's only part of a full medical evaluation. If you have any serious or worsening symptoms, please speak to a doctor right away—especially if you suspect a life-threatening condition.
(References)
* Graham, B. L., et al. (2019). Standardisation of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. *European Respiratory Journal*, *54*(3), 1900138. PMID: 31439601.
* Hanania, N. A., et al. (2020). Bronchodilator Reversibility: Update on Clinical Interpretation and Management. *Pulmonary Therapy*, *6*(3), 421-432. PMID: 32671569.
* Tashkin, D. P., et al. (2017). Bronchodilator responsiveness in COPD: a systematic review and meta-analysis. *European Respiratory Journal*, *50*(6), 1701042. PMID: 29284693.
* Nair, A., et al. (2021). Bronchodilator reversibility testing: Clinical applications and interpretation. *Indian Journal of Chest Diseases & Allied Sciences*, *63*(4), 255-266. PMID: 35084931.
* Pellegrino, R., et al. (2021). Bronchodilator Reversibility Testing: Methodological Considerations and Clinical Relevance. *Frontiers in Physiology*, *12*, 684123. PMID: 33967812.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.